期刊文献+

生物可吸收支架的循证医学证据和展望 被引量:6

下载PDF
导出
摘要 生物可吸收支架的研发历史可追溯到大约20年前,尽管根据目前的试验结果,还不能肯定生物可吸收支架一定优于目前正应用于临床的药物洗脱支架(DES),需要解决降解时间及支架内血栓、支架通过病变的能力以及支架释放后内皮化速度和炎症对损伤的反应机制等问题,但生物可吸收支架的降低靶部位的再狭窄率,中长期内支架被局部组织吸收从而降低该部位受到的药物及炎症刺激等多种优势已逐渐显现,很可能成为未来的重要发展研究方向。
出处 《中国循环杂志》 CSCD 北大核心 2014年第8期561-563,共3页 Chinese Circulation Journal
  • 相关文献

同被引文献39

  • 1Joner M, Finn AV, Farb A, ct al. Pathology of drug-eluting stents in hmnans: delayed healing and lale thrombotic risk [ J ]. J Am Coll Cardio1,2006,48 ( 1 ) : 193-202. DOI: 10. 101 6/j. jacc. 2006. 03. 042.
  • 2Byrne R A, Joner M, Kastrati A. Polymer coatings anti delayed arterial healing following drug-eluting stent implantation [ J ]. Minerva Car- dioangiol,2009,57 ( 5 ) :567-584.
  • 3Park SJ, Kang SJ, Vimlani R, et al. ln-stent neoatherosclerosis : a fi- nal common pathway of late stcnt failure [ J ]. J Am Coil Cardiol, 2012,59 ( 23 ) :2051-2057. DOI : 10.1016/j. jacc. 2011.10. 909.
  • 4Urban P, Valdas M, Menown I, et al. Outcomes following implantation of the Biolirnus A9-cluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registry [ J ]. Catheter Cardiovasc Interv, 2015,86 (7) : l 151-1160. DOI : 10. 1 002/ccd. 25892.
  • 5Costa RA, Abizaid A, Mehran R, ct al. Polymer-Free biolimus a9- Coated stents in the treatment of De Novo coronary lesions: 4- and 12-Month angiographic Follow-Up and final 5-Year clinical outcomes of the prospective, multicenter BioFreedom FIM clinical trial [ J ]. JACC Cardiovasc Interv, 2016,9 ( 1 ) : 51-64. DOI : 10. 1016/j. jcin. 2015.09. 008.
  • 6Navarse EP,Tandjung K,Claessen B,et al. Safety and efficacy out-comes of first and second Generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice : comprehensive network meta-analysis [ J ]. BMJ,2013,347 : f6530.
  • 7Schurtz G, Delhaye C, Hurt C, et al. Biodegradable polymer Biolimus- eluting stent (Nobori) for the treatment of coronary artery lesions: review of concept and clinical results [ J ]. Meal Devices ( Auckl), 2014,7:35-43. DOI: 10. 2147/MDER. $44051.
  • 8Cassese S, Fusaro M, Byrne RA, et al. Clinical outcomes of patients treated with Nobori biolinms-eluting stent: Meta-analysis of random- ized trials [ J ]. lnt J Cardiol, 2014, 175 ( 3 ) : 484491. DOI: 10.lOl6/j, ijeard. 2014.06.014.
  • 9Danzi GB, Piccolo R, Galasso G, et al. Nobori biolimus-eluting stent vs. permanent polymer drug-eluting stents in patients undergoing percutaneous coronaiT intervention [ J ] . Cire J, 2014,78 ( 8 ) : 1858- 1866.
  • 10Ye Y,Xie H,Zeng Y,et al. Efficaey and safety of biodegradable pol- ymer biolimus-eluting stents versus durable polymer drug-eluting stents: a meta-analysis[ J]. PLoS One,2013,8( 11 ) : e78667. DOI: 10. 1371/journal. pone. 0078667.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部